AlphaYouSC
Insider selling
Sandra Calvin sold $335K of Travere Therapeutics, Inc. (TVTX) stock
Sandra Calvin, SVP, Chief Accounting Officer of Travere Therapeutics, Inc. (TVTX), sold 5,375 shares of TVTX stock worth $335K, per an SEC Form 4 filed Sep 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 15, 2026, 3 days before it was made public.
TVTX has moved +0.6% since the trade date, from $62.51 to $62.86 (Sep 21, 2026 close).
- Traded
- Sep 15, 2026
- Disclosed
- Sep 18, 2026
- Filing delay
- 3 days
- Price since
- +0.6%
- Role
- SVP, Chief Accounting Officer
- Source
- SEC Form 4
More TVTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.